|
JMY expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.117700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.417600E-02 |
| Normal-vs-Stage2 |
6.034300E-02 |
| Normal-vs-Stage3 |
4.060400E-03 |
| Normal-vs-Stage4 |
2.007900E-02 |
| Stage1-vs-Stage2 |
8.411000E-01 |
| Stage1-vs-Stage3 |
2.032800E-01 |
| Stage1-vs-Stage4 |
5.240400E-01 |
| Stage2-vs-Stage3 |
4.973800E-01 |
| Stage2-vs-Stage4 |
7.263400E-01 |
| Stage3-vs-Stage4 |
7.519400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.423000E-03 |
| Normal-vs-AfricanAmerican |
5.164800E-01 |
| Normal-vs-Asian |
6.765600E-02 |
| Caucasian-vs-AfricanAmerican |
2.089400E-01 |
| Caucasian-vs-Asian |
6.217000E-01 |
| AfricanAmerican-vs-Asian |
4.113800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.616100E-03 |
| Normal-vs-Female |
1.289970E-02 |
| Male-vs-Female |
6.812000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.156200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.358250E-02 |
| Normal-vs-Age(61-80Yrs) |
1.041750E-03 |
| Normal-vs-Age(81-100Yrs) |
6.785900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.013600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.145600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.000000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.447400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.436000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.016800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.369800E-02 |
| Classical-VS-Follicular |
1.192810E-01 |
| Classical-VS-Other |
4.491400E-01 |
| Classical-VS-Normal |
5.919800E-02 |
| Tall-VS-Follicular |
3.713000E-01 |
| Tall-VS-Other |
7.679200E-01 |
| Tall-VS-Normal |
3.500300E-03 |
| Follicular-VS-Other |
8.275400E-01 |
| Follicular-VS-Normal |
1.049840E-02 |
| Other-VS-Normal |
1.709840E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.343900E-03 |
| Normal-vs-N1 |
2.568400E-02 |
| N0-vs-N1 |
9.140600E-01 |
|
|
